HVC
KIN

Healthcare Value Capital’s Kindred Biosciences, Inc. KIN Stock Holding History

Healthcare Value Capital’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50,000
Closed -$463K – 35
2014
Q3 		$463K Hold
50,000
– – 0.45% 26
2014
Q2 		$932K Buy
+50,000
New +$849K 0.78% 22
2014
Q1 		– Sell
-50,000
Closed -$559K – 51
2013
Q4 		$559K Buy
+50,000
New +$596K 0.41% 31

Other funds holding KIN

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Healthcare Value Capital's KIN Position: Q4 2014 in Review

Healthcare Value Capital sold out of Kindred Biosciences, Inc. (KIN) in Q4 2014, closing a stake of 50,000 shares — an estimated $463K sold.

Healthcare Value Capital first reported a position in KIN in Q4 2013 and held it in 3 quarters. The position peaked at $932K in Q2 2014. 64 funds tracked by Wall St. Rank hold KIN as of Q4 2014.

  • Healthcare Value Capital reported no remaining Kindred Biosciences, Inc. position as of Q4 2014 after selling out during the quarter.
  • Healthcare Value Capital sold 50,000 Kindred Biosciences, Inc. shares in Q4 2014, an estimated $463K.
  • Healthcare Value Capital first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 3 quarters.
  • Healthcare Value Capital's Kindred Biosciences, Inc. position peaked at $932K in Q2 2014.
  • 64 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2014.

Based on Healthcare Value Capital's 13F filing for Q4 2014, filed 13 Feb 2015.